Weekly Chart on MRNAThe price is moving into a range which was already tested in 2021.
Possible positive price action on the go on this last wave. But it may be too early to say it.
4MRNA trade ideas
3/29 Watchlist + NotesSPY - I had no real bias going into today's session other than mentioning last night that downside was more likely to come today because of the failed 2U daily created on monday. We closed slightly red after seeing a decent drop to the high 393 area, forming a weak bearish 2D. Going into wednesday (3/29), I am hoping to see some downward continuation to the 392/390 levels tomorrow to test that range. Key word is hoping. I remain neutral with my personal bias as we have no real clear direction this week still. Given that we closed very weak to the downside leads me to believe we can ultimately go either way tomorrow, but once again, playing what is in front of us I have to be looking more so to the downside.
Watchlist + Bias:
DIS - 2-1 Daily: Slightly Bullish
MRNA - 2-1 Daily: Bearish.
PEP - 2-1 Daily: Bearish
FDX - 3-1- Weekly: Neutral
Main Watch:
MRNA - Back in our main spotlight for the 2nd time this week is MRNA. There is a 2-1 daily setup that is within a bearish week with a lot of room to the downside due to a huge FVG on the daily. Looking to target Monday's low of 145.36 and the 50% retrace point of the original FVG at 144.72. Will only play downside and not upside if markets pump tomorrow
Also heavily watching FDX still as the 3-1 weekly has not broken out yet. Hourly chart stuck in a flat channel currently just consolidating.
Yesterdays Main Watch:
NVDA - (Status:) Winner (Personally Enter?) No
I mentioned we had downside targets and that I wanted to play with markets momentum. I missed entry due to being in class and not being able to trade, but I saw how it played out. Broke short entry level in the first few minutes of market open and dumped past our 260 target to the mid 258 level. Cons ran a little over 75% from entry and realistically I would have caught the full move due to the dump being so consistent and strong before reversing.
Watchlist Stats For The Week:
2/2 On Spy Predictions
2/2 On Main Watch Plays
Top Winner: NVDA (75%+)
Personal Stats:
3/5 for the week.
Overall Green/Red? Green
iS it lookin 2 ht two50?There is a high probability that it can hit 250 in next 3 months, it must break above 170 first. Some big news around 170 can make it hit 250.
3/22 Watchlist + NotesSPY - Once again we were bullish going into today and ended up getting that upside movement we wanted. Tomorrow is FOMC so no real prediction for tomorrows movement other than some chop leading up to the news. As far as the news goes, I am leaning more on the bullish side but quite honestly that is purely a guess. Trading light tomorrow if I take anything, and not trading after news comes out.
Watchlist:
MRNA - 3-1: Bullish
BIDU - 2-1: Neutral
Main Watch:
MRNA - Nothing special about this setup other than it being a 3-1 daily setup and seeing that it has more room to the upside to test a daily FVG around 157.70
Top winner from yesterdays watchlist:
GOOG - 2-1 daily broke to the upside and had a gorgeous uptrend day. Calls ran just under 240% from where the long entry (yesterdays high) was
MRNA to $167After the MacD turned bullish for Moderna, I believe we will finish the harmonic pattern until we hit the trend line at around 167-170.
Not financial advice, good luck to all :)
MRNAXLV did outperform today and so did most health related stocks.
I think this is a beginning of a reversal for the health care sector.
MRNA closed with some bullish volume and a double bottom that will push it to 172 gap close.
Has some downtrend resistance at around 155 but I think it will cut through it.
Bounced off its weekly 200.
$MRNA Watching 786 fib Nice cypher on MRNA, Do not care for the name but it can work.. I will post if get long
MRNA // 134.94 118.55 our support pointsWe need to hold on at 134.94. Our second support point is at 118.55. Those who want to buy from resistance should look for a wedge close in the daily timeframe . Pay attention to the wedge resistance in the weekly timeframe .
$MRNA What Up$MRNA started playing this since it was in the low $20s and then got rid of it at the start of this year. And IMO this is headed under $100. It will get a kick start when the next Pandemic happens and WHO rules lockdowns across the world. Regardless of the hype, I don't see any reason to take a position in this ticker. The only outcome is, EXIT for me :) Although it does have a promising technology but it will not be able to generate the kind of revenue it did with the Pandemic vax
MRNA | This is a BUY | BOUNCEModerna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
$MRNA with a bearish outlook following its earnings #StocksThe PEAD projected a bearish outlook for $MRNA after a negative under reaction following its earnings release placing the stock in drift D .
MRNA LONGOVERSOLD and previous support level are at $139-138. Buy and sell when it gets close to 200 MA (blue line) close to the $150-155 range.
Will test 180sIf breaks above 180 it can run to 260s midterm
If gets rejected at 180 will need to come back down and try to form a higher low
modernaI have no exact idea about this stock. it could move in either direction as it is holding - in the middle of both 20EMA&50MA. this is one of the best stocks to add watchlist but not opened a position yet. I will be back to this stock mid-next week after see monthly close on it
Possible Head and ShouldersPrice is above the neckline which is strong support until broken.
ES with the break of the neckline and a downtrend.
Short interest around 4%.
Earnings are estimated to be on 2-23.
A lot could depend on earnings.
No recommendation.
Short with clean break of the neckline.
TBox for MRNAConsolidation areas based on Price Action.
EMAs are not usefull at the moment with the price showing negative price action and a bearish setup.
About to dipPrice failed to break the $210 resistance and is going back down. It shouldn't take too long to fall, and maybe in a few weeks from now is going to try to break the $210 again, but not now.
Bearish trade idea on MRNAWe should continue lower to about 151 and some change and have a retest into about 165-170 -- Looking for a bearish play and roll over!
Moderna (MRNA) ... Time for a shot in the Arm ?Moderna (MNRA). This is a potential long trade if it reaches my area of interest in my PRZ (price reversal zone).
A nicely formed ABCD formation together with a Harmonic Crab / Alternate Bat (depending where X starts), come together in the mid to low $160s.
(This also happens to come full circle to the recent December 2022 low.)
This together with positive momentum hopefully sets up one or both of the targets objectives.
I wouldn't chase this and beware of broader markets.
Earnings are expected Feb. 23rd at $4.70.
As always DYODD.
I will monitor
S,
mrnathe stock name is mrna which means to die, and the ema crossover suggests so, when the emas crossover like they have crossed over right now it is known as mini maharaja death crossover, so short
MRNAModerna shows 145 or 115 as a target on the short side..
Building a very good base up here or it's preparing to break below 115 to target 80$.
Nonetheless been short since 210/share.
MRNA Short$MRNA in the ol wedge formation is going to send this thing down to the low 100's at least.
U.S. no longer in a pandemic will send the company earnings to doo doo once more.
